Carmen Nussbaum-Krammer

Prof. Dr. Carmen Nussbaum-Krammer

Chair of Neuroanatomy, Ludwig-Maximilians-Universität München, Munich, Bavaria, Germany
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2015 in Molecular Cell
Verified
Journal Article
Closed access
XGXuechao Gao
Xuechao Gao
MCMarta Carroni
Marta Carroni
CNCarmen Nussbaum-Krammer
Carmen Nussbaum-Krammer
AMAxel Mogk
Axel Mogk
NNNadinath B. Nillegoda
Nadinath B. Nillegoda
BBBernd Bukau
Bernd Bukau

8 January 2015 in Journal of Visualized Experiments
Verified
Journal Article
Open access
PDF file
CNCarmen Nussbaum-Krammer
Carmen Nussbaum-Krammer
MNMário F. Neto
Mário F. Neto
RBRenée M. Brielmann
Renée M. Brielmann
JPJesper S. Pedersen
Jesper S. Pedersen
RMRichard I. Morimoto
Richard I. Morimoto
Prion-like propagation of protein aggregates has recently emerged as being implicated in many neurodegenerative diseases. The goal of...

1 July 2020 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
ENEliana Nachman
Eliana Nachman
AWAnne S. Wentink
Anne S. Wentink
KMKarine Madiona
Karine Madiona
LBLuc Bousset
Luc Bousset
Taxiarchis KatsinelosTaxiarchis Katsinelos
Taxiarchis Katsinelos
CNCarmen Nussbaum-Krammer
Carmen Nussbaum-Krammer
The accumulation of amyloid Tau aggregates is implicated in Alzheimer's disease (AD) and other tauopathies. Molecular chaperones are known to maintain protein homeostasis. Here, we show that an ATP-dependent human chaperone system disassembles Tau fibrils in vitro. We found that this function is mediated by the core chaperone HSC70, assisted by specific cochaperones, in particular class B J-domain proteins and a heat shock protein 110 (Hsp110)-type nucleotide exchange factor (NEF). The Hsp70 disaggregation machinery processed recombinant fibrils assembled from all six Tau isoforms as well as Sarkosyl-resistant Tau aggregates extracted from cell cultures and human AD brain tissues, demonstrating the ability of the Hsp70 machinery to recognize a broad range of Tau aggregates. However, the chaperone activity released monomeric and small oligomeric Tau species, which induced the aggregation of self-propagating Tau conformers in a Tau cell culture model. We conclude that the activity of the Hsp70 disaggregation machinery is a double-edged sword, as it eliminates Tau amyloids at the cost of generating new seeds.

6 October 2020 in Frontiers in Aging Neuroscience
Verified
Journal Article
Open access
PDF file
JTJessica Tittelmeier
Jessica Tittelmeier
ENEliana Nachman
Eliana Nachman
CNCarmen Nussbaum-Krammer
Carmen Nussbaum-Krammer
Aberrant accumulation of misfolded proteins into amyloid deposits is a hallmark in many age-related neurodegenerative diseases, including Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease (HD), and amyotrophic lateral sclerosis (ALS). Pathological inclusions and the associated toxicity appear to spread through the nervous system in a characteristic pattern during the disease. This has been attributed to a prion-like behavior of amyloid-type aggregates, which involves self-replication of the pathological conformation, intercellular transfer, and the subsequent seeding of native forms of the same protein in the neighboring cell. Molecular chaperones play a major role in maintaining cellular proteostasis by assisting the (re)-folding of cellular proteins to ensure their function or by promoting the degradation of terminally misfolded proteins to prevent damage. With increasing age, however, the capacity of this proteostasis network tends to decrease, which enables the manifestation of neurodegenerative diseases. Recently, there has been a plethora of studies investigating how and when chaperones interact with disease-related proteins, which have advanced our understanding of the role of chaperones in protein misfolding diseases. This review article focuses on the steps of prion-like propagation from initial misfolding and self-templated replication to intercellular spreading and discusses the influence that chaperones have on these various steps, highlighting both the positive and adverse consequences chaperone action can have. Understanding how chaperones alleviate and aggravate disease progression is vital for the development of therapeutic strategies to combat these debilitating diseases.

12 February 2019 in Cold Spring Harbor Perspectives in Biology
Verified
Journal Article
Closed access
PDF file
AWAnne Wentink
Anne Wentink
CNCarmen Nussbaum-Krammer
Carmen Nussbaum-Krammer
BBBernd Bukau
Bernd Bukau
Aberrant protein aggregation is a defining feature of most neurodegenerative diseases. During pathological aggregation, key proteins transition from their native state to alternative conformations, which are prone to oligomerize into highly ordered fibrillar states. As part of the cellular quality control machinery, molecular chaperones can intervene at many stages of the aggregation process to inhibit or reverse aberrant protein aggregation or counteract the toxicity associated with amyloid species. Although the action of chaperones is considered cytoprotective, essential housekeeping functions can be hijacked for the propagation and spreading of protein aggregates, suggesting the cellular protein quality control system constitutes a double-edged sword in neurodegeneration. Here, we discuss the various mechanisms used by chaperones to influence protein aggregation into amyloid fibrils to understand how the interplay of these activities produces specific cellular outcomes and to define mechanisms that may be targeted by pharmacological agents for the treatment of neurodegenerative conditions.

30 July 2015 in The EMBO Journal
Verified
Journal Article
Closed access
PDF file
JKJanine Kirstein
Janine Kirstein
DMDaisuke Morito
Daisuke Morito
TKTaichi Kakihana
Taichi Kakihana
MSMunechika Sugihara
Munechika Sugihara
AMAnita Minnen
Anita Minnen
RMRichard I Morimoto
Richard I Morimoto